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Jaundice is observed during the first week of life in approximately 60% term and 80% of preterm infants [1]. Due to social and family constraints; the pediatricians are 
practicing early discharge from hospitals [2]. This increases the 
risk of significant jaundice where subsequently intervention might 
be required. The problems encountered due to hyperbilirubinemia 
are neurological manifestations as seen in kernicterus leading 
brain damage. This is also seen in a full-term newborn with no 
apparent evidence of hemolysis [3]. Therefore, it is difficult to 
predict which infants are at increased risk for significant and 
relatively late hyperbilirubinemia. There is an obvious need 
to implement follow-up programs or to develop predictive 
guidelines that will enable the physicians to predict or to identify 
which of the early discharged newborn will develop significant 
hyperbilirubinemia [2].
Knowledge of infants at risk of developing jaundice allows 
simple bilirubin reducing methods to be implemented before 
jaundice becomes significant and could influence a decision 
regarding early discharge from Hospital. Predicting the high-
risk neonates for subsequent hyperbilirubinemia will also help 
in detecting infants at low risk for postnatal hyperbilirubinemia 
and minimize an unnecessary prolongation of hospitalization or 
hospital readmission for hyperbilirubinemia [4]. We therefore, 
undertook this study to predict the value of cord bilirubin level 
beyond which a newborn might develop jaundice requiring 
intervention.
MATERIALS AND METHODS
The study was conducted in the Department of Paediatrics, 
Swami Rama Himalayan University, Dehradun, over a period 
of 12 months from 1st January 2015 to December 31st 2015. The 
study was approved by Institutional Ethics Committee. Written 
consent was obtained from the parents or legal guardians before 
recruitment. Only full-term and late preterm (gestational age 
>34 weeks and <42 weeks) neonates with Apgar score >7 in 
1st min and 10 at 15th min were recruited to the study. Neonates 
of both gender delivered consecutively by any type of delivery in 
the Department of Obstetrics and Gynecology were prospectively 
enrolled in the study. Neonates with any significant illness 
(sepsis, respiratory distress syndrome, asphyxia, and infant of 
diabetic mother) that could aggravate hyperbilirubinemia, birth 
weight <2000 g and babies with Rh and ABO incompatibility 
were excluded from the study.
Soon after the birth when a neonate was separated from 
placenta, 10 ml of blood was taken by passive let down in plain and 
ethylenediaminetetraacetic acid vials and were immediately sent 
for assessment and analysis. Hemolysed samples were discarded 
and the cord blood was not taken in mother with negative blood 
group considering the possibility of Rh incompatibility. Repeat 
serum bilirubin levels were assessed at 72 h of life by venous 
sampling of newborns, and it was sent immediately for bilirubin 
estimation by blinded observer technique.
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A detailed maternal and perinatal history and clinical findings 
were recorded on a pre-structured format along with the laboratory 
investigations. Gestational age of the enrolled infants was 
determined on the basis of the date of the past menstrual period or 
first-trimester ultrasound (wherever available). It was confirmed 
by the expanded Ballard score done within 24 h of life [5]. All 
enrolled babies were followed up clinically for the development 
of jaundice using Kramer Dermal Scale* till discharge and further 
on follow-up till 1 month of age. Detailed physical examination 
was carried out daily by the investigator. Those babies who on 
visual inspection had Jaundice where the bilirubin level seemed 
to be above the 95th centile for age in hours of life as per Bhutani 
hour specific bilirubin nomogram were further investigated by 
estimation of serum total and direct bilirubin.
The newborns detected to have pathological hyperbilirubinemia 
were further investigated by doing Direct Coombs test, 
complete blood count, reticulocyte count, and peripheral smear 
and were managed according to standard protocols as per 
guidelines of American Academy of Pediatrics subcommittee on 
hyperbilirubinemia. The decision to start or stop phototherapy 
was based on AAP guidelines [6]. Bilirubin and its fractions 
were measured by spectrophotometric technique on an automated 
analyzer Unicel DXC 800 manufactured by Beckman Coulter. 
Neonates who were discharged before the third day of life were 
asked to return on day 3 for estimation of serum bilirubin at 72 h 
of life. Neonates who did not come for follow-up or in whom the 
72 h serum bilirubin could not be collected were excluded from 
the study.
Result was analysed using statistical software statistical 
package for the social sciences 22. Qualitative data were expressed 
in frequency and percentage, while quantitative data were 
expressed in mean ± standard deviation. Paired t-test, receiver 
operating characteristic (ROC) curve, and logistic regression 
were used to analyze the pattern of bilirubin levels. The strength 
of association was found using Pearson’s Correlation curve.
RESULTS
A total of 767 deliveries occurred during the study period of which 
100 were enrolled in the study (Figure 1). Out of the total delivery 
sample, 350 were excluded as they were early preterms. From the 
remaining 417 neonates, 216 were assessed since the others had 
congenital anomalies or maternal risk factors or other risk factors 
which could lead to jaundice. The sample size of 100 (out of 216) 
was finalized once we observed saturation in the results, i.e., we 
started observing a significant pattern in estimating the cutoff value 
of cord bilirubin beyond which a neonate could have developed 
jaundice. Among the sample size of 100, 12 cases were excluded 
since their total bilirubin levels at 72 h of life were <2 mg/dl [7].
The baseline characteristic of the mothers and newborn 
enrolled in the study is given in Tables 1 and 2, respectively.
With ROC analysis, (Figure 2), the mean cord bilirubin level 
was 1.923±0.966 mg/dl. The area under curve was 0.791. The 
mean total bilirubin at 72 h was 10.56±3.18 mg/dl. There were 16 
newborns who had serum bilirubin >14 mg/dl at 72 h (Table 3). 
The cord bilirubin of >2.02 had sensitivity and specificity of 
87.5% and 70.8%, respectively, with positive predictive value 
of 0.39 and negative predictive value of 0.965. The strength of 
association of cord bilirubin >2.02 mg/dl and requirement of 
phototherapy at 72 h was found to be significant (p<0.001).
DISCUSSION
Serum bilirubin levels are usually 1-3 mg/dl at the time of birth 
and rise at the rate of <5 mg/dl/day, peaking at 2-3 days in term 
neonates [7]. Our aim was to quantify the relationship between 
cord blood bilirubin with peak serum bilirubin levels at 72-84 h of 
life. Cord blood estimation was chosen because it is a non-invasive 
method and the results are available within few hours after birth. 
Thus, the babies at risk for developing hyperbilirubinemia can 
be detected at birth in a non-invasive way if the neonate leaves 
the hospital within the first few postnatal days. In addition, the 
use of cord blood bilirubin values may help predict infants with 
low risk for hyperbilirubinemia and minimize an unnecessary 
prolongation of hospitalization [8-10]. In a study by Taksande 
et al., prevalence was 9.5% only because the cutoff for significant 
hyperbilirubinemia on 3rd day of life was taken as 17 mg% [11].
Table 2: Baseline characteristics of newborn enrolled
Neonatal characteristics Type Mean±SD n (%)
Gestational age (weeks) 37.82±1.09
Sex Female - 31 (35.2)
Male - 57 (64.7)
Blood group A+ve - 8 (20)
B+ve - 11 (27.5)
AB+ve - 2 (5)
O+ve - 19 (47.5)
B-ve - 3 (3)
Birth trauma - - 0 (0)
Weight (kg) - 2.77±0.39 -
Cord blood hemoglobin (g/dl) - 14.86±1.626 -
SD: Standard deviation
Table 1: Baseline characteristics of mother enrolled
Maternal characteristics Type n (%)
Mode of delivery LSCS 54 (61.3)
Normal 34 (38.6)






MSL - 14 (16)
Oxytocin therapy - 2 (2.27)
Neonatal jaundice in previous sibling - 1 (1.2)
PROM 2 (2.27)
MSL: Meconium stained liquor, PROM: Premature rupture of membrane, 
LSCS: Lower Segment Caesarean Section
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Nagwa et al. observed that there was a positive correlation 
between umbilical cord serum bilirubin and subsequent 
development of hyperbilirubinemia and newborn with 
cord bilirubin >4 mg/dl were a group at risk of developing 
severe hyperbilirubinemia and were presented to have mean 
serum bilirubin levels higher than 16 mg/dl at 72 h with peak 
17±4.3 mg/dl at 68±17.5 h of postnatal age [12]. Knudsen in 
his study demonstrated that jaundiced newborn presented with 
higher umbilical cord bilirubin levels than newborns without 
clinical jaundice. In addition, the number of jaundiced newborns 
undergoing phototherapy was significantly higher when these 
levels were >2.0 mg/dl, in comparison with the number of 
jaundiced newborns with no need for treatment and whose 
bilirubin levels were ≤2.0 mg/dl [10]. Ahire et al. predicted 
the serum bilirubin >3 mg/dl on the first day of life had 100% 
sensitivity of predicting subsequent jaundice at 48 h of life with 
bilirubin levels >10.58 mg/dl [13].
Knupfer et al. observed that serum bilirubin >1.74 mg/
dl on the first day of life had 97% sensitivity of predicting a 
subsequent serum bilirubin levels >16 mg/dl at 72 h of life. At 
this critical serum bilirubin value, the negative predictive value 
was 99.8% [14]. Rataj et al. reported that if cord bilirubin was 
<1 mg/dl jaundice occurred in 2.4% newborns, whereas 89% of 
infants with cord bilirubin >2.5 mg/dl became jaundiced [15]. 
Taksande et al., in their study, predicted that cord bilirubin level 
>2 mg/dl had 89.5% sensitivity, and high (98.7%) negative 
predictive value, and fairly low (38.6%) of positive predictive 
value [11]. Dhanwadkar et al. found that 2.2% neonates 
developed significant jaundice with cord total bilirubin levels 
>3 mg/dl with high specificity (86%) and positive predictive 
value (92%) [16].
Pradhan et al. found significant association of high total 
cord bilirubin levels of >2.5 mg/dl and subsequent development 
Table 3: Relationship between cord bilirubin and serum bilirubin at 72 h
Serum bilirubin Number of neonates n (%)
Cord bilirubin >2.02 mg/dl Cord bilirubin <2.02 mg/dl Total
2-13 mg/dl 21 (60) 51 (97) 72 (81.8)
>14 mg/dl 14 (40) 2 (3) 16 (18.2)
Total 35 (39.8) 53 (60.2) 88 (100)
Figure 1: Flowchart showing neonates enrolled
Figure 2: Receiver operating characteristic curve showing association 
of cord bilirubin levels and requirement of phototherapy at 72 h of 
life
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of jaundice within 24 h of life with sensitivity (84.1%) and 
specificity (88.5%) [17]. In our study, the cord bilirubin level 
>2.02 mg/dl had the highest sensitivity (87.5%), and this critical 
bilirubin levels had a very high negative findings, a critical 
cutoff level of cord bilirubin was 2.02 mg/dl predicted 88% of 
newborn who developed jaundice. However, the cord bilirubin 
<2.02 mg/dl did not completely exclude the development of 
significant hyperbilirubinemia. Only 3% of newborn with cord 
bilirubin levels of <2.02 mg/dl developed jaundice. A 96% of 
negative predictive value suggests that the measurement of cord 
serum bilirubin can help in identifying those newborn who are 
unlikely to require further evaluation and intervention.
Just like all studies, our case study also has some limitations. 
The sample size was small which causes difficulty in creating 
significant relationships between the two values of bilirubin levels. 
The volume of cord blood collected was inadequate in few of the 
cases. In addition, some of the blood collected got hemolyzed 
which could not be considered for analysis. Some of the neonates 
did not turn up in outpatient department for follow-up and the 
access to sample collection at 72 h of life was denied by some 
of the parents which made it difficult to consider them as cases.
CONCLUSION
Cord bilirubin level >2.02 mg/dl had sensitivity and specificity of 
89.5% and 87.5% and can be taken as a cutoff value above which, 
a neonate would develop hyperbilirubinemia and would require 
phototherapy.
REFERENCES
1. Stoll BJ, Kleigman RM. In: Behrman RE, Kleigman RM, Jenson HB. 
Jaundice and hyperbilirubinemia in new-born: In Nelson Textbook of 
Pediatrics. 20th ed. Philadelphia, PA: WB Saunders Company; 2015. 
p. 871-3.
2. Carty EM, Bradley CF. A randomized, controlled evaluation of early 
postpartum hospital discharge. Birth. 1990;17(4):199-204.
3. Rosenfeld J. Umbilical cord bilirubin levels as a predictor of subsequent 
hyperbilirubinemia. J Fam Pract. 1986;23(6):556-8.
4. Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breast-fed term 
newborns. Pediatrics. 1995;96:730-3.
5. Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R. New 
ballard score, expanded to include extremely premature infants. J Pediatr. 
1991;119(5):417-23.
6. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. 
Management of hyperbilirubinemia in the newborn infant 35 or more weeks 
of gestation. Pediatrics. 2004;114(1):297-316.
7. Gregory ML, Martin CR, Cloherty JP. Neonatal hyperbilirubinemia. In: 
Cloherty JP, Eichenwald EC, Hansen AR, Stark AR, editors. Manual of 
Neonatal Care. 7th ed. New Delhi (India): Wolter Kluwer; 2011. p. 304.
8. Watchko JF. Neonatal Indirect hyperbilirubinemia and kernicterus. In: 
Gleason CA, Devaskar SU, editors. Avery’s Diseases of the Newborn. 9th ed. 
Philadelphia (USA): Elsevier; 2012. p. 1123-42.
9. Suchonska B, Wielgos M, Bobrowska K, Marianowski L. Concentration 
of bilirubin in the umbilical blood as an indicator of hyperbilirubinemia in 
newborns. Ginekol Pol. 2004;75(10):749-53.
10. Knudsen A. Prediction and non-invasive assessment of neonatal jaundice in 
the term healthy newborn infant. Acta Paediatr. 1996;85(4):393-7.
11. Taksande A, Vilhekar K, Jain M, Zade P, Atkari S, Verkey S. Prediction of 
the development of neonatal hyperbilirubinemia by increased umbilical cord 
blood bilirubin. Curr Pediatr Res. 2005:9(1-2):59.
12. Nagwa H, Elgayae A, Salah MH. Cord blood bilirubin as a predictor of 
neonatal hyper-bilirubinemia. Med J Cairo Univ. 2012;80(2):31-6.
13. Ahire N, Sonawane R, Gaikwad R, Patil S, Sonawane T. Study of correlation 
of cord blood bilirubin with neonatal hyper bilirubinaemia. MVP J Med Sci. 
2016;3(1):60-6.
14. Knüpfer M, Pulzer F, Gebauer C, Robel-Tillig E, Vogtmann C. Predictive 
value of umbilical cord blood bilirubin for postnatal hyperbilirubinaemia. 
Acta Paediatr. 2005;94(5):581-7.
15. Rataj J, Kornacka M, Korman E. Usefulness of measuring bilirubin levels 
in cord blood for predicting hyperbilirubinemia in newborns. Ginekol Pol. 
1994;65(6):276-80.
16. Dhanwadkar SS, Rasalam CS, Masood Z. Effectiveness of early clinical 
assessment and bilirubin estimation for prediction of neonatal hyper 
bilirubinaemia. Int J Contemp Pediatr 2016;3(2):477-84.
17. Pradhan A, Lamichaney R, Sharma V. Cord Blood Bilirubin level as a 
predictor of development of pathological hyperbilirubinemia in new-borns. 
Int J Contemp Pediatr. 2017;4(4):1519-24.
Funding: None; Conflict of Interest: None Stated.
How to cite this article: Sehgal P, Wasim S, Chandar V, Gupta A, Rawat A, 
Kalra V, Bhat NK, Pandita N. Cord bilirubin levels as a predictive marker 
for neonatal hyperbilirubinemia: A prospective study. Indian J Child Health. 
2017; 4(4):571-574.
